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a  b  s  t  r  a  c  t
With  few  exceptions,  immunization  supply  chains  in  developing  countries  continue  to  face  chronic  difﬁ-
culties in  providing  uninterrupted  availability  of potent  vaccines  up  to service  delivery  levels,  and  in the
most efﬁcient  manner  possible.  As  these  countries  struggle  to keep  pace  with  an  ever  growing  number
of  vaccines,  more  and  more  Ministries  of  Health  are  considering  options  of  engaging  the  private  sector  to
manage  vaccine  storage,  handling  and  distribution  on their  behalf.  Despite  this  emerging  trend,  there  is
limited  evidence  on the  beneﬁts  or challenges  of this  option  to improve  public  supply  chain  performance
for  national  immunization  programmes.  To  bridge  this  knowledge  gap, this  study  aims  to shed  light on  the
value  proposition  of  outsourcing  by  documenting  the speciﬁc  experience  of  the  Western  Cape  Province
of  South  Africa.  The  methodology  for this  review  rested  on  conducting  two  key  supply  chain  assessments
which  allowed  juxtaposing  the  performance  of the  government  managed  segments  of the vaccine  supply
chain  against  those  managed  by  the  private  sector.  In particular,  measures  of effective  vaccine  manage-
ment  best  practice  and  temperature  control  in the  cold  chain  were  analysed.  In  addition,  the  costs  of
engaging  the  private  sector  were  analysed  to get  a better  understanding  of  the  economics  underpinning
outsourcing  vaccine  logistics.  The  results  from  this  analysis  conﬁrmed  some  of the  theoretical  beneﬁts
of  outsourcing  to the  private  sector.  Yet,  if the  experience  in  the  Western  Cape  can  be deemed  a  success-
ful one,  there  are  several  policy  and  practice  implications  that  developing  countries  should  be  mindful
of  when  considering  engaging  the  private  sector.  While  outsourcing  can  help  improve  the performance
of  the vaccine  supply  chain,  it has  the potential  to  do  the  reverse  if done  incorrectly.  The  ﬁndings  and
lessons  learnt  from  the  Western  Cape  experience  can  serve  as  a step  towards  understanding  the role  of
the  private  sector  in immunization  supply  chain  and  logistics  systems  for developing  countries.
© 2015  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
With few exceptions, immunization supply chains in developing
ountries continue to face chronic difﬁculties in providing uninter-
upted availability of potent vaccines up to service delivery levels,
nd in the most efﬁcient manner possible. Combined with the
truggles to keep pace with an ever increasing number of vaccines
o introduce, many government-managed systems remain crip-
led by inefﬁciencies [1–4]. Recent WHO  and UNICEF assessments
n 65 low and lower-middle income countries have revealed that
ew countries meet minimum standards for effective vaccine stor-
ge, distribution, handling, and stock management [5,6]. Without
∗ Corresponding author. Tel.: +41 22 794 4238.
E-mail address: lydonp@who.int (P. Lydon).
ttp://dx.doi.org/10.1016/j.vaccine.2015.03.042
264-410X/© 2015 The Authors. Published by Elsevier Ltd. This is an open access
y-nc-nd/4.0/).signiﬁcant investments to upgrade government-run immunization
supply chains that already tie up signiﬁcant resources, the aspira-
tions to strengthen routine immunization as a whole will remain
quixotic at best. Another option to such large investments is for
national government in developing countries to consider engag-
ing the private sector to manage supply chain functions on their
behalf. Supply chain theory postulates that, if managed correctly,
the outsourcing of vaccine logistics to a 3rd party private sector
logistics service provider can lead to a reduction in total deliv-
ery costs, better on-time delivery of vaccines, higher adherence to
temperature thresholds, better vaccine management and handling
practises, reduced inventory costs, and greater ability to increase
volume and scale (volume ﬂexibility) than a government managed
supply chain system. While the theory suggests that outsourcing
can be more cost-effective and lead to higher levels of service per-
formance, there is limited evidence or published case studies in
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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eveloping countries documenting the theory against the practice
hen it comes to vaccines.
This study aims to shed light on the value proposition of
utsourcing immunization supply chain functions to the private
ector by documenting the speciﬁc experience of the Western Cape
rovince of South Africa. Indeed, in 2005 the Western Cape decided
o enter into a public private partnership with a private sector
ogistics service provider (LSP) known as the “Distribution Agree-
ent” [7–9]. Enduring challenges of stock management, the lack
f adequate cold chain storage facilities, and overall inefﬁciencies
n the government run distribution system for vaccines, were the
rimary reason leading the Western Cape Department of Health
WCDH) to relegate certain supply chain functions previously man-
ged “in-house”, to a 3rd party logistics service provider that had a
omparative advantage in storing, handling and transporting vac-
ines at lower costs and at higher levels of service. For a fee levied
n the value of the vaccines procured, the outsourced private sec-
or LSP was responsible for guaranteeing the cold chain storage and
anagement of vaccines for the province, and their effective trans-
ort from their provincial warehouse directly to health centres. On
he basis of two  key assessments conducted, the ﬁndings show that
utsourcing resulted in a better vaccine management and handling
ractises, and higher adherence to temperature thresholds in the
old chain. In addition, the analysis of the cost of the outsourc-
ng arrangement point to lower costs than those that would be
ncurred is the same logistics function were done “in-house” by the
rovincial government. Lastly, key lessons learnt and policy and
ractice implications were teased out. From this experience, it is
oped that these ﬁndings will serve as a step towards understand-
ng the potential role of the private sector in immunization supply
hain and logistics systems for developing countries.. Methods
For this study, both qualitative and quantitative evidence was
ollect along the different vaccine supply chain segments in effect
Fig. 1. Schematic of the supply chain network (2015) 3429–3434
between the provincial vaccine store and health centres. One of
the particularities was the presence of two  types of supply chain
segments that needed to be reviewed separately: a 2 tiered sup-
ply chain segment that was  outsourced to the private sector LSP
which covered the distribution of vaccines from provincial level to
47% of health centres in the province (or 131 Health Centres); and
a 3 tiered supply chain segment where vaccines are managed by
public sector district hospitals and where the district governments
are responsible for storing and transporting vaccines the remaining
53% of health centres in the Western Cape Province (Fig. 1).
Data collection was  carried out in both the 2 tiered (outsourced)
and 3 tiered (government managed) supply chain segments during
two key assessments. In addition to the provincial vaccine ware-
house, a total of 10 sites were sampled for these two  assessments,
including 2 district hospitals and 8 health facilities. First, an EVM
assessment was carried out using the standardized methodology
and tool developed by WHO  in order to determine whether vaccine
management practices are up to international norms and stan-
dards, and to diagnose overall strengths and weaknesses in the
vaccine supply chain according to eight key dimensions: tempera-
ture control in the cold chain; sufﬁcient cold chain storage capacity;
quality of the infrastructure; efﬁciency in the maintenance systems
for the infrastructure; stock management processes; vaccine distri-
bution practices; compliance with vaccine management policies;
and use of a logistics management information systems (LMIS) to
track and trace vaccines [10]. The EVM methodology aggregates
the results so that each dimension is given a score between 0% and
100% at the end of the assessment. For the supply chain system
to be considered up to standard on a dimension, a score of 80%
or more is required [10]. Second, an in-depth temperature moni-
toring assessment was conducted to determine whether vaccines
were being kept in the recommended temperature ranges, at all
times during storage and transport to ensure that their potency
was not compromised by damaging temperature excursions. The
WHO  study protocol for temperature monitoring in the vaccine cold
chain was the basis of the methodology [11]. The temperature of
 speciﬁc of the Western Cape Province.
P. Lydon et al. / Vaccine 33 (2015) 3429–3434 3431
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he cold chain for storage was monitored over an 8 month period at
he provincial vaccine warehouse and the 10 sampled sites across
he 2 and 3 tiered segments of the Western Cape immunization
upply chain. In addition, the temperature was monitored over the
ame period during the transportation of vaccines along the corre-
ponding distribution routes [12]. A total of 24 WHO  pre-qualiﬁed
emperature recorders (Log Tag TRIX-8) were used for logging tem-
eratures every 15 min, and data was reviewed against the WHO
enchmarks for temperature excursion events indicating that the
otency of the vaccine may  have been compromised: freeze alarm
orresponding to reading below −0.5 ◦C for 60 min  or more; and
eat alarm corresponding to readings above 8.0 ◦C for 10 h or more.
Lastly, to determine whether the cost of outsourcing was  eco-
omically viable an economic analysis using standardize methods
eveloped by the WHO  was conducted for two periods of 2005
nd 2010 that represent the ﬁrst year of the outsourcing arrange-
ent and the year of this study [13]. Because it was  not possible to
onduct two economic analyses that would have allowed a direct
omparison between the cost of the outsourced system against an
stimate of what it would have cost the Western Cape Department
f Health to store vaccine at provincial level and distribute these up
o health centre, the costs of the outsourced system were compared
o cost of logistics benchmarks from other studies [20,23].
. Results
.1. Effective vaccine management
The effective vaccine management assessment results have
ighlighted the extent to which the outsourced logistics service
rovider outperformed the government run supply chain system
n all relevant EVM dimensions [14]. The overall EVM score for the
egments of the immunization supply chain covered by the out-
ourcing arrangement exceeded the 80% benchmark level when
veraging across all 8 vaccine management dimensions. In contrast,
his overall score was 63% for the supply chain segments managed
y the government. The main differences in performance are most
ronounced on the criteria for temperature (the lack of basic knowl-
dge on managing temperatures for vaccines); distribution (due to
he absence of frozen water-pack conditioning to prevent freezing
accines during transport); shortcoming on the vaccine logisticson effective vaccine management.
information systems (the lack of clear procedures for forecasting
and ordering vaccines, for recording key indicators like vaccine
wastage and for monitoring temperature during transport) (Fig. 2).
It is noteworthy that the private sector LSP performed less well
than the government-run segments of the vaccine supply chain
for two  EVM dimensions relating to sufﬁcient cold chain storage
capacity and compliance with vaccine management policies.
3.2. Temperature control
The ﬁndings on the temperature monitoring study conﬁrmed
the ability of the outsourced LSP in maintaining vaccines within
WHO recommended temperature range of 2–8 ◦C during both
storage and transport. Over the 8 month monitoring period, the
temperature averaged 4.9 ◦C (4.4–5.6 ◦C range) for storage at the
provincial level warehouse. No temperature alarms or excursions
that would expose vaccines to damaging freezing or heat temper-
atures occurred. On the transport side, the ﬁndings show that in
85% of deliveries, vaccines were transported under good temper-
ature control conditions. The reasons why the LSP did not achieve
100% was due to the occasional use of a 4th party courier services to
transport vaccines to certain parts of the province where distances
were large against a small order of vaccines. Since it was  not cost-
effective for the outsourced LSP to do the transportation themselves
in these instances, they resorted to pay a courier service for deliv-
ering vaccines. This poor practise was  to their detriment since their
overall temperature performance was penalised by the inability of
the courier service to maintain adequate cold chain temperatures
during transport and vaccine were put at risk.
For the 3 tiered segment of the supply chain managed by the
government, the system was unable to maintain the same level of
temperature control during storage and transport. This is illustrated
in Fig. 3 that represents the full temperature proﬁle for the vaccines
that reached health centres from provincial level via segments of
the supply chain managed by the government. Maintaining ade-
quate temperature in the cold chain was most challenging at health
centre level. While the average temperature inside all the health
centre fridges monitored averaged 3.1 ◦C over the 8 month period,
the range of temperatures around this average was 0.9–9.2 ◦C, and
suggests that temperature breaches occurred on both ends of the
recommended 2.0–8.0 ◦C range. A deeper analysis indicated that
3432 P. Lydon et al. / Vaccine 33 (2015) 3429–3434
Fig. 3. Illustrative temperature proﬁle for the segment of the vaccine supply chain managed by the government. (a) The x-axis is indicative of time as the vaccines move from
the  provincial warehouse to health centres refrigerators. The peaks and troughs in the temperature curve at health centre level reﬂect the poor performance of the vaccine
r ately 
t
i
t
T
p
b
m
w
p
h
3
v
8
a
s
T
p
t
a
t
u
t
$
b
q
t
o
a
(
o
[
o
i
In benchmarking against what it would cost the government
to manage the vaccine supply chain, various ﬁgures are of interest
in presenting. A assessment of the vaccine supply chain and logis-
tics system in Thailand indicate that the cost of the governmentefrigerators equipping government run health clinics and their inability to adequ
emperatures over the 8 months study period for temperature monitoring.
n 30% of health centres refrigerators, vaccines were exposed to
emperature below 0 ◦C and were freeze alarms were triggered.
he main reason is the poor quality of the cold chain equipment
rovided for the immunization programme which has shown to
e largely inadequate for storing vaccines [12,15]. On the govern-
ent run transport system, the ﬁndings indicated that vaccines
ere more at risk from heat exposure than if they were trans-
orted directly from the outsourced LSP although no heat damage
ad occurred during these temperature excursions [12].
.3. Economic analysis
The costing analysis indicates that the total cost of the pri-
ate sector LSP to perform outsourced services amounted to US$
22,429 for the year 2010. These costs represented 5.7% of the over-
ll procurement cost of vaccines and is slightly less than the 6.0%
ervice fee charged to the government in the outsourcing contract.
he warehousing costs for the vaccine is by far the largest cost com-
onent representing 75% of the overall costs to the LSP whereas
he cost of transporting vaccines from province to health centres
ccounted for the remaining 25% (Fig. 4).
Since the start of the outsourcing arrangement in 2005, the costs
o private sector LSP rose due to the signiﬁcant increase in the vol-
me of vaccines to manage (see Table 1). Between 2005 and 2010,
he logistics cost per child experienced a ﬁve-fold increase from
1.3 to $7.9. Likewise, the logistics cost per dose administered rose
y a factor of 10 from $0.06 to $0.71. These increases are the conse-
uence of important investments that the private sector LSP needed
o make to accommodate the 3 new vaccines introduced—the size
f the provincial warehouse was expanded (77% increase in surface
rea); more staff were recruited to manage the growing workload
from 3 to 16 full-time equivalents) and the cost of warehousing
verheads increased substantially (due rising cost of electricity)
16]. The combined effect of all these factors meant that their cost
f doing business went from US$ 120,750 in 2005 to US$ 822,429
n 2010.maintain stable temperatures irrespective diurnal or seasonal changes in ambient
While the cost in value terms rose, the fee charged by the
private sector LSP remained unchanged at 6% between 2005 and
2010. And relative to benchmark ﬁgures from other studies, the
6% fee charged by the private sector LSP is considered economical.
Within the Western Cape province, one comparator is the 5% fee
charged to the provincial government by the semi-private Central
Medical Depot for the provincial storage of non-temperature sen-
sitive pharmaceuticals. This fee does not include cold chain storage
nor any transportation of these pharmaceuticals to sub-provincials
stores or health centres win  the Western Cape.Fig. 4. Cost breakdown for the outsourcing fee in 2010.
P. Lydon et al. / Vaccine 33
Table  1
Evolution of key immunization supply chain cost indicators—2005 and 2010.
2005 2010
Vaccine turnover ($US) US$ 2.0 million US$ 14.5 million
Vaccine volume (cm3 per fully
immunized child)
46.2 cm3 5780.2 cm3
LSP service fee 6.0% 6.0%
Public sector service fee (from the
CMD)*
5.0% 5.0%
Cost to the LSP of providing the
service ($US)
US$ 120,750 US$ 822,429
Per  child under one year of age $1.3 $7.9
Per  dose administered $0.061 $0.706
Per  US$1000 worth of vaccines $58.4 $56.9
%  value of vaccines 5.8% 5.7%
* Represents the fee charged by the central medical depot in the Western Cape
Province. This fee is charged to the Western Cape Department of Health for the
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supply chains [22], it will be imperative to bridge the knowledgerovincial storage of non-cold chain pharmaceutical products and does not include
ny  transportation to sub-provincials stores or health centres.
anaged system represents 31% of the value of vaccine procured
20]. This ﬁgure is consistent with another estimate of 28% based
n the average cost of a government-run supply chain system
or vaccines in Eastern and Southern Africa countries [24]. Lastly,
he benchmark logistics cost for government managed health
upply chains for none temperature sensitive pharmaceuticals
ave been shown to range anywhere between 13% and 44% of
he procurement cost of the health commodity in many African
ountries [23].
. Discussion
When reviewed against effective vaccine management, temper-
ture and economic performance measures, the results from this
utsourcing case study conﬁrm some of the theoretical beneﬁts
f outsourcing vaccine supply chain functions to the private sec-
or. Overall, the ﬁndings suggest that performance was greater for
he 2 tiered segments of the supply chain that were outsourced
province to health centre), than the 3 tiered segments managed
y the provincial government (province to district hospitals to
ealth centre). Furthermore, the 6% fee charged by the private sec-
or LSP is considered economical, particularly given that the fee
emained unchanged after three new vaccines were introduced into
he Western Cape Province in 2010—these signiﬁcantly raised the
alue and volume of vaccines that the private sector LSP had to
arehouse and distribute.
If the experience in the Western Cape can be deemed a success-
ul one on the basis of performance measures assessed, there are
everal limitations to this case-study that need to be mentioned
16]. The ﬁrst relates to the inability to make direct compar-
sons between the private and public sector performance measures
n the Western Cape Province system. These required alterna-
ive approaches to juxtapose the two systems. For the EVM and
emperature monitoring results, the comparisons were made by
ontrasting the measures for the segments of the supply chain
overed by the outsourcing arrangement with those where the
rovincial government choose to manage vaccines themselves
ndependently of the agreement—these segments of the supply
hain are close but not identical. Arguably, the analysis would
ave been more robust if the comparator was another province
n South Africa where the supply chain is entirely managed by the
rovincial government. For the economic analysis, the comparison
f the 6% service charge for the outsourcing arrangement against
ther benchmark ﬁgures is a clear limitation. A direct comparison
etween the cost of the outsourced system against an estimate of
hat it would have cost the Western Cape Department of Health (2015) 3429–3434 3433
to perform the same logistics function “in-house” would have been
more robust.
The second limitation is the inability to expand on the qual-
itative aspects of the outsourcing experience documented for
the Western Cape that highlight a darker side to the outsourc-
ing arrangement. Given the policy and practice implications of
these qualitative aspects, it is important to summarize the ﬁve
key shortcomings that are primarily attributable to: (i) the lack
of management oversight of the contract by the WCDH; (ii) the
weaknesses in the outsourcing contract itself with insufﬁciently
detailed service level agreements; (iii) the lack of a monitoring
and evaluation framework with key performance indicators; (iv)
the decentralized and sluggish government clearance on ﬁnancial
transactions to purchase vaccines that resulted in important delays
in payment to the LSP; and (v) the lack of a process to share critical
planning information between both parties—particularly on vac-
cine forecasting. Unfortunately, all of these drawback were present
in the Western Cape experience. While these shortcomings don’t
undermine the theoretical beneﬁts of outsourcing, they do speak to
the importance of ensuring that the government provides ongoing
contractual oversight and maintain a functional relationship with
the private sector logistics service provider [16].
On the basis of the Western Cape outsourcing experience, there
are clear lessons learned for developing countries. While outsourc-
ing to the private sector can help improve the performance of the
vaccine supply chain, the success of engaging the private sector
will hinge on ensuring that: (i) all stakeholders are consulted in
advance of a decision to outsource vaccine logistics to discuss the
possible beneﬁts and constraints, especially at the lowest levels
(district and health centre levels); (ii) important supply chain per-
formance assessments of the government managed vaccine supply
chain are conducted upfront to ensure that the right choice of what
supply chain functions to outsource; (iii) the costs of outsourcing
are conducted and compared with the cost of keeping the func-
tions “in house”;  and (iv) the right private sector 3rd party LSP is
selected and a strong contract is established with a sufﬁciently
detailed service level agreement; a strong monitoring and eval-
uation framework with key performance indicators; and a robust
process within the government health authorities to oversee and
manage the outsourcing contract.
Even if our understanding of how to couple private sector
outsourcing to a government managed supply chain system for vac-
cines remains limited for developing country settings, the review
of the Western Cape Province experience provides an incremental
step towards ﬁlling the knowledge gap. The lessons learned from
this case study highlight many considerations that should be care-
fully weighed before any decision is made by other countries to
outsource to the private sector. Beyond recommending that more
evidence on the beneﬁts and challenges of outsourcing be gen-
erated, there is need to develop a framework and approach for
countries on how to consider and select outsourcing opportunities
as a means of improving public sector vaccine supply chain per-
formance [17]. In addition, there is a need to develop guidance and
tools for analysing the potential cost and performance of these out-
sourcing opportunities that can support the design and assessment
of an outsourcing options [18].
While outsourcing has enormous potential to increase sup-
ply chain performance of an existing system when done correctly
[19,20], it is not a panacea. Venturing down this path will require
new sets of skills and will come with a host of new sets of challenges
[21]. If the trend continues and more and more developing coun-
try governments consider engaging the private sector in vaccinegaps to ensure countries can be adequately advised and supported
so that beneﬁts of outsourcing in the setting can be leveraged
effectively.
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